Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Faça VM[au]:

Profiling Cell Lines Nuclear Sub-proteome. Poersch A et al. Methods Mol Biol. (2017)

DIA is not a new mass spectrometry acquisition method. Martins-de-Souza D et al. Proteomics. (2017)

Selective Reaction Monitoring for Quantitation of Cellular Proteins. Faça VM et al. Methods Mol Biol. (2017)

Search results

Items: 1 to 50 of 54

1.

A High-Content Screening Approach to Identify MicroRNAs Against Head and Neck Cancer Cell Survival and EMT in an Inflammatory Microenvironment.

Sangiorgi B, de Souza FC, Mota de Souza Lima I, Dos Santos Schiavinato JL, Corveloni AC, Thomé CH, Araújo Silva W Jr, Faça VM, Covas DT, Zago MA, Panepucci RA.

Front Oncol. 2019 Nov 8;9:1100. doi: 10.3389/fonc.2019.01100. eCollection 2019.

2.

Deubiquitination of phosphoribosyl-ubiquitin conjugates by phosphodiesterase-domain-containing Legionella effectors.

Wan M, Sulpizio AG, Akturk A, Beck WHJ, Lanz M, Faça VM, Smolka MB, Vogel JP, Mao Y.

Proc Natl Acad Sci U S A. 2019 Nov 19;116(47):23518-23526. doi: 10.1073/pnas.1916287116. Epub 2019 Nov 5.

PMID:
31690664
3.

A proteomics outlook towards the elucidation of epithelial-mesenchymal transition molecular events.

Silvestrini VC, Lanfredi GP, Masson AP, Poersch A, Ferreira GA, Thomé CH, Faça VM.

Mol Omics. 2019 Oct 7;15(5):316-330. doi: 10.1039/c9mo00095j. Review.

PMID:
31429845
4.

Proteomic Identification and Time-Course Monitoring of Secreted Proteins During Expansion of Human Mesenchymal Stem/Stromal in Stirred-Tank Bioreactor.

Mizukami A, Thomé CH, Ferreira GA, Lanfredi GP, Covas DT, Pitteri SJ, Swiech K, Faça VM.

Front Bioeng Biotechnol. 2019 Jun 26;7:154. doi: 10.3389/fbioe.2019.00154. eCollection 2019.

5.

High-content screen in human pluripotent cells identifies miRNA-regulated pathways controlling pluripotency and differentiation.

de Souza Lima IM, Schiavinato JLDS, Paulino Leite SB, Sastre D, Bezerra HLO, Sangiorgi B, Corveloni AC, Thomé CH, Faça VM, Covas DT, Zago MA, Giacca M, Mano M, Panepucci RA.

Stem Cell Res Ther. 2019 Jul 8;10(1):202. doi: 10.1186/s13287-019-1318-6.

6.

The lipid raft protein NTAL participates in AKT signaling in mantle cell lymphoma.

Ferreira GA, Thomé CH, Simão AMS, Scheucher PS, Silva CLA, Chahud F, Ciancaglini P, Leopoldino AM, Rego EM, Faça VM, Dos Santos GA.

Leuk Lymphoma. 2019 Nov;60(11):2658-2668. doi: 10.1080/10428194.2019.1607326. Epub 2019 May 7.

PMID:
31060403
7.

The contribution and perspectives of proteomics to uncover ovarian cancer tumor markers.

Carvalho VP, Grassi ML, Palma CS, Carrara HHA, Faça VM, Candido Dos Reis FJ, Poersch A.

Transl Res. 2019 Apr;206:71-90. doi: 10.1016/j.trsl.2018.11.001. Epub 2018 Nov 20. Review.

PMID:
30529050
8.

The highly efficient powerhouse in the Wistar audiogenic rat, an epileptic rat strain.

Dechandt CRP, Vicentini TM, Lanfredi GP, Silva-Jr RMP, Espreafico EM, de Oliveira JAC, Faça VM, Garcia-Cairasco N, Alberici LC.

Am J Physiol Regul Integr Comp Physiol. 2019 Mar 1;316(3):R243-R254. doi: 10.1152/ajpregu.00254.2018. Epub 2018 Dec 5.

PMID:
30517024
9.

Quantification of Coagulation Factor VIII by Selective Reaction Monitoring.

do Nascimento Filho EG, Lanfredi GP, Abreu-Neto MS, Covas DT, Faça VM.

Methods Mol Biol. 2018;1674:275-282. doi: 10.1007/978-1-4939-7312-5_22.

PMID:
28921445
10.

Selective Reaction Monitoring Mass Spectrometry for Quantitation of Glycolytic Enzymes in Postmortem Brain Samples.

Lanfredi G, Reis-de-Oliveira G, Saia-Cereda VM, Guest PC, Martins-de-Souza D, Faça VM.

Adv Exp Med Biol. 2017;974:205-212. doi: 10.1007/978-3-319-52479-5_16.

PMID:
28353237
11.

Profiling Cell Lines Nuclear Sub-proteome.

Poersch A, Maria AG, Palma CS, Grassi ML, Albuquerque D, Thomé CH, Faça VM.

Methods Mol Biol. 2017;1550:35-46. doi: 10.1007/978-1-4939-6747-6_4.

PMID:
28188521
12.

DIA is not a new mass spectrometry acquisition method.

Martins-de-Souza D, Faça VM, Gozzo FC.

Proteomics. 2017 Apr;17(7). doi: 10.1002/pmic.201700017. Epub 2017 Mar 3.

PMID:
28130891
13.

Selective Reaction Monitoring for Quantitation of Cellular Proteins.

Faça VM.

Methods Mol Biol. 2017;1546:213-221.

PMID:
27896771
14.

Differential Gel Electrophoresis (DIGE) Evaluation of Naphthoimidazoles Mode of Action: A Study in Trypanosoma cruzi Bloodstream Trypomastigotes.

Brunoro GV, Faça VM, Caminha MA, Ferreira AT, Trugilho M, de Moura KC, Perales J, Valente RH, Menna-Barreto RF.

PLoS Negl Trop Dis. 2016 Aug 23;10(8):e0004951. doi: 10.1371/journal.pntd.0004951. eCollection 2016 Aug.

15.

Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control.

Grassi ML, Palma CS, Thomé CH, Lanfredi GP, Poersch A, Faça VM.

J Proteomics. 2017 Jan 16;151:2-11. doi: 10.1016/j.jprot.2016.06.009. Epub 2016 Jul 6.

PMID:
27394697
16.

DSP30 enhances the immunosuppressive properties of mesenchymal stromal cells and protects their suppressive potential from lipopolysaccharide effects: A potential role of adenosine.

Sangiorgi B, De Freitas HT, Schiavinato JL, Leão V, Haddad R, Orellana MD, Faça VM, Ferreira GA, Covas DT, Zago MA, Panepucci RA.

Cytotherapy. 2016 Jul;18(7):846-59. doi: 10.1016/j.jcyt.2016.04.004.

PMID:
27260206
17.

Proteomic Analysis of Mesenchymal Stem Cells.

Faça VM, Orellana MD, Greene LJ, Covas DT.

Methods Mol Biol. 2016;1416:509-19. doi: 10.1007/978-1-4939-3584-0_31.

PMID:
27236693
18.

A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics.

Poersch A, Grassi ML, Carvalho VP, Lanfredi GP, Palma CS, Greene LJ, de Sousa CB, Carrara HHA, Candido Dos Reis FJ, Faça VM.

J Proteomics. 2016 Aug 11;145:226-236. doi: 10.1016/j.jprot.2016.05.005. Epub 2016 May 21.

PMID:
27222041
19.

Proteomic Analysis of Epithelial to Mesenchymal Transition (EMT) Reveals Cross-talk between SNAIL and HDAC1 Proteins in Breast Cancer Cells.

Palma Cde S, Grassi ML, Thomé CH, Ferreira GA, Albuquerque D, Pinto MT, Ferreira Melo FU, Kashima S, Covas DT, Pitteri SJ, Faça VM.

Mol Cell Proteomics. 2016 Mar;15(3):906-17. doi: 10.1074/mcp.M115.052910. Epub 2016 Jan 13.

20.

The secretome analysis by high-throughput proteomics and multiple reaction monitoring (MRM).

Faça VM, Palma CS, Albuquerque D, Canchaya GN, Grassi ML, Epifânio VL, de Oliveira EB.

Methods Mol Biol. 2014;1156:323-35. doi: 10.1007/978-1-4939-0685-7_22.

PMID:
24791999
21.

Comparative metabolism of cellulose, sophorose and glucose in Trichoderma reesei using high-throughput genomic and proteomic analyses.

Dos Santos Castro L, Pedersoli WR, Antoniêto ACC, Steindorff AS, Silva-Rocha R, Martinez-Rossi NM, Rossi A, Brown NA, Goldman GH, Faça VM, Persinoti GF, Silva RN.

Biotechnol Biofuels. 2014 Mar 21;7(1):41. doi: 10.1186/1754-6834-7-41.

22.

Disrupting membrane raft domains by alkylphospholipids.

Gomide AB, Thomé CH, dos Santos GA, Ferreira GA, Faça VM, Rego EM, Greene LJ, Stabeli RG, Ciancaglini P, Itri R.

Biochim Biophys Acta. 2013 May;1828(5):1384-9. doi: 10.1016/j.bbamem.2013.01.017. Epub 2013 Feb 1.

23.

Linker for activation of T-cell family member2 (LAT2) a lipid raft adaptor protein for AKT signaling, is an early mediator of alkylphospholipid anti-leukemic activity.

Thomé CH, dos Santos GA, Ferreira GA, Scheucher PS, Izumi C, Leopoldino AM, Simão AM, Ciancaglini P, de Oliveira KT, Chin A, Hanash SM, Falcão RP, Rego EM, Greene LJ, Faça VM.

Mol Cell Proteomics. 2012 Dec;11(12):1898-912. doi: 10.1074/mcp.M112.019661. Epub 2012 Sep 22.

24.

A quantitative proteomic and transcriptomic comparison of human mesenchymal stem cells from bone marrow and umbilical cord vein.

Miranda HC, Herai RH, Thomé CH, Gomes GG, Panepucci RA, Orellana MD, Covas DT, Muotri AR, Greene LJ, Faça VM.

Proteomics. 2012 Aug;12(17):2607-17. doi: 10.1002/pmic.201200111. Epub 2012 Aug 7.

PMID:
22778083
25.

Production of human factor VIII-FL in 293T cells using the bicistronic MGMT(P140K)-retroviral vector.

Fontes AM, Melo FU, Greene LJ, Faça VM, Lin Y, Gerson SL, Covas DT.

Genet Mol Res. 2012 Mar 22;11(1):775-89. doi: 10.4238/2012.March.22.8.

26.

SK-HEP cells and lentiviral vector for production of human recombinant factor VIII.

da Rosa NG, Swiech K, Picanço-Castro V, Russo-Carbolante EM, Soares Neto MA, de Castilho-Fernandes A, Faça VM, Fontes AM, Covas DT.

Biotechnol Lett. 2012 Aug;34(8):1435-43. doi: 10.1007/s10529-012-0925-4. Epub 2012 Apr 10.

PMID:
22488441
27.

Human mesenchymal stromal cell proteomics: contribution for identification of new markers and targets for medicine intervention.

Faça VM.

Expert Rev Proteomics. 2012 Apr;9(2):217-30. doi: 10.1586/epr.12.9. Review.

PMID:
22462791
28.

Quantitative proteomic profiling identifies protein correlates to EGFR kinase inhibition.

Kani K, Faca VM, Hughes LD, Zhang W, Fang Q, Shahbaba B, Luethy R, Erde J, Schmidt J, Pitteri SJ, Zhang Q, Katz JE, Gross ME, Plevritis SK, McIntosh MW, Jain A, Hanash S, Agus DB, Mallick P.

Mol Cancer Ther. 2012 May;11(5):1071-81. doi: 10.1158/1535-7163.MCT-11-0852. Epub 2012 Mar 12.

29.

Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer.

Schliekelman MJ, Gibbons DL, Faca VM, Creighton CJ, Rizvi ZH, Zhang Q, Wong CH, Wang H, Ungewiss C, Ahn YH, Shin DH, Kurie JM, Hanash SM.

Cancer Res. 2011 Dec 15;71(24):7670-82. doi: 10.1158/0008-5472.CAN-11-0964. Epub 2011 Oct 10.

30.

Lung cancer signatures in plasma based on proteome profiling of mouse tumor models.

Taguchi A, Politi K, Pitteri SJ, Lockwood WW, Faça VM, Kelly-Spratt K, Wong CH, Zhang Q, Chin A, Park KS, Goodman G, Gazdar AF, Sage J, Dinulescu DM, Kucherlapati R, Depinho RA, Kemp CJ, Varmus HE, Hanash SM.

Cancer Cell. 2011 Sep 13;20(3):289-99. doi: 10.1016/j.ccr.2011.08.007.

31.

Impact of protein stability, cellular localization, and abundance on proteomic detection of tumor-derived proteins in plasma.

Fang Q, Kani K, Faca VM, Zhang W, Zhang Q, Jain A, Hanash S, Agus DB, McIntosh MW, Mallick P.

PLoS One. 2011;6(7):e23090. doi: 10.1371/journal.pone.0023090. Epub 2011 Jul 29.

32.

Interaction of 10-(octyloxy) decyl-2-(trimethylammonium) ethyl phosphate with mimetic membranes and cytotoxic effect on leukemic cells.

dos Santos GA, Thomé CH, Ferreira GA, Yoneda JS, Nobre TM, Daghastanli KR, Scheucher PS, Gimenes-Teixeira HL, Constantino MG, de Oliveira KT, Faça VM, Falcão RP, Greene LJ, Rego EM, Ciancaglini P.

Biochim Biophys Acta. 2010 Sep;1798(9):1714-23. doi: 10.1016/j.bbamem.2010.05.013. Epub 2010 May 19.

33.

Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery.

Pitteri SJ, JeBailey L, Faça VM, Thorpe JD, Silva MA, Ireton RC, Horton MB, Wang H, Pruitt LC, Zhang Q, Cheng KH, Urban N, Hanash SM, Dinulescu DM.

PLoS One. 2009 Nov 19;4(11):e7916. doi: 10.1371/journal.pone.0007916.

34.

Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings.

Katayama H, Paczesny S, Prentice R, Aragaki A, Faca VM, Pitteri SJ, Zhang Q, Wang H, Silva M, Kennedy J, Rossouw J, Jackson R, Hsia J, Chlebowski R, Manson J, Hanash S.

Genome Med. 2009 Apr 29;1(4):47. doi: 10.1186/gm47.

35.

Comparative study of SPR and ELISA methods based on analysis of CD166/ALCAM levels in cancer and control human sera.

Vaisocherová H, Faca VM, Taylor AD, Hanash S, Jiang S.

Biosens Bioelectron. 2009 Mar 15;24(7):2143-8. doi: 10.1016/j.bios.2008.11.015. Epub 2008 Nov 27.

PMID:
19157844
36.

In-depth proteomics to define the cell surface and secretome of ovarian cancer cells and processes of protein shedding.

Faça VM, Hanash SM.

Cancer Res. 2009 Feb 1;69(3):728-30. doi: 10.1158/0008-5472.CAN-08-3087. Epub 2009 Jan 20. Review.

37.

Brain-specific proteins decline in the cerebrospinal fluid of humans with Huntington disease.

Fang Q, Strand A, Law W, Faca VM, Fitzgibbon MP, Hamel N, Houle B, Liu X, May DH, Poschmann G, Roy L, Stühler K, Ying W, Zhang J, Zheng Z, Bergeron JJ, Hanash S, He F, Leavitt BR, Meyer HE, Qian X, McIntosh MW.

Mol Cell Proteomics. 2009 Mar;8(3):451-66. doi: 10.1074/mcp.M800231-MCP200. Epub 2008 Nov 4.

38.

Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains.

Faça VM, Ventura AP, Fitzgibbon MP, Pereira-Faça SR, Pitteri SJ, Green AE, Ireton RC, Zhang Q, Wang H, O'Briant KC, Drescher CW, Schummer M, McIntosh MW, Knudsen BS, Hanash SM.

PLoS One. 2008 Jun 18;3(6):e2425. doi: 10.1371/journal.pone.0002425.

39.

A mouse to human search for plasma proteome changes associated with pancreatic tumor development.

Faca VM, Song KS, Wang H, Zhang Q, Krasnoselsky AL, Newcomb LF, Plentz RR, Gurumurthy S, Redston MS, Pitteri SJ, Pereira-Faca SR, Ireton RC, Katayama H, Glukhova V, Phanstiel D, Brenner DE, Anderson MA, Misek D, Scholler N, Urban ND, Barnett MJ, Edelstein C, Goodman GE, Thornquist MD, McIntosh MW, DePinho RA, Bardeesy N, Hanash SM.

PLoS Med. 2008 Jun 10;5(6):e123. doi: 10.1371/journal.pmed.0050123.

40.

A mouse plasma peptide atlas as a resource for disease proteomics.

Zhang Q, Menon R, Deutsch EW, Pitteri SJ, Faca VM, Wang H, Newcomb LF, Depinho RA, Bardeesy N, Dinulescu D, Hung KE, Kucherlapati R, Jacks T, Politi K, Aebersold R, Omenn GS, States DJ, Hanash SM.

Genome Biol. 2008;9(6):R93. doi: 10.1186/gb-2008-9-6-r93. Epub 2008 Jun 3.

41.

Isoform analysis of LC-MS/MS data from multidimensional fractionation of the serum proteome.

Krasnoselsky AL, Faca VM, Pitteri SJ, Zhang Q, Hanash SM.

J Proteome Res. 2008 Jun;7(6):2546-52. doi: 10.1021/pr7007219. Epub 2008 Apr 18.

PMID:
18419151
42.

Mining the plasma proteome for cancer biomarkers.

Hanash SM, Pitteri SJ, Faca VM.

Nature. 2008 Apr 3;452(7187):571-9. doi: 10.1038/nature06916. Review.

PMID:
18385731
43.

Plasma proteome profiling of a mouse model of breast cancer identifies a set of up-regulated proteins in common with human breast cancer cells.

Pitteri SJ, Faca VM, Kelly-Spratt KS, Kasarda AE, Wang H, Zhang Q, Newcomb L, Krasnoselsky A, Paczesny S, Choi G, Fitzgibbon M, McIntosh MW, Kemp CJ, Hanash SM.

J Proteome Res. 2008 Apr;7(4):1481-9. doi: 10.1021/pr7007994. Epub 2008 Feb 27.

PMID:
18311905
44.

Preliminary functional characterization, cloning and primary sequence of Fastuosain, a cysteine peptidase isolated from fruits of Bromelia fastuosa.

Cabral H, Leopoldino AM, Tajara EH, Greene LJ, Faça VM, Mateus RP, Ceron CR, de Souza Judice WA, Julianod L, Bonilla-Rodriguez GO.

Protein Pept Lett. 2006;13(1):83-9.

PMID:
16454675
45.

Low molecular weight squash trypsin inhibitors from Sechium edule seeds.

Laure HJ, Faça VM, Izumi C, Padovan JC, Greene LJ.

Phytochemistry. 2006 Feb;67(4):362-70. Epub 2006 Jan 9.

PMID:
16406091
46.

Efficient constitutive expression of Bacillus subtilis xylanase A in Escherichia coli DH5alpha under the control of the Bacillus BsXA promoter.

Ruller R, Rosa JC, Faça VM, Greene LJ, Ward RJ.

Biotechnol Appl Biochem. 2006 Jan;43(Pt 1):9-15.

PMID:
15982188
48.

Isolation of two plant proteinases in latex from Carica candamarcensis acting as mitogens for mammalian cells.

Gomes MT, Mello VJ, Rodrigues KC, Bemquerer MP, Lopes MT, Faça VM, Salas CE.

Planta Med. 2005 Mar;71(3):244-8.

PMID:
15770545
49.

Determination and reoxidation of the disulfide bridges of a squash-type trypsin inhibitor from Sechium edule seeds.

Faça VM, Pereira SR, Laure HJ, Greene LJ.

Protein J. 2004 Jul;23(5):309-15.

PMID:
15328886
50.

Cloning and expression of an acidic platelet aggregation inhibitor phospholipase A2 cDNA from Bothrops jararacussu venom gland.

Roberto PG, Kashima S, Soares AM, Chioato L, Faça VM, Fuly AL, Astolfi-Filho S, Pereira JO, França SC.

Protein Expr Purif. 2004 Sep;37(1):102-8.

PMID:
15294287

Supplemental Content

Support Center